LIPID inCode tests patients to identify familial hypercholesterolemia and prevent cardiovascular disease

Following favorable FDA feedback for the treatment of liver disease, the company is preparing further pre-IND meetings with the FDA for the treatment of atherosclerosis and familial hypercholesterolemia